Physician

Theodore A Gancayco, MD

According to 2025 Medicare claims, Theodore Gancayco, MD (NPI: 1932217262) practices ophthalmology in the Washington, DC-MD market, with the plurality of this provider's patient population coming from The District, DC. This provider's primary affiliated billing organization is CHESAPEAKE EYE CARE AND LASER CENTER LLC (NPI: 1548296262; TIN: 52-2124249) and primary practice location at 20017-2110.

Gancayco's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,453 traditional Medicare patients, billed 6,435 HCPCS/CPT codes, and received $562,691 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 2,710 prescription claims across 591 beneficiaries totaling $395,289 in drug costs, led by Rocklatan (Netarsudil Mesylat/Latanoprost). Open Payments data shows 22 records totaling $498. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $217,658 to $395,289. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$281K$563K2015 Medicare payment: $491,138 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $392,836 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $465,513 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $446,598 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $390,194 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $350,999 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $473,362 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $468,733 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $487,034 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $562,691 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,7166,184$491,138
20161,5115,287$392,836
20171,6756,753$465,513
20181,6106,294$446,598
20191,3705,382$390,194
20201,6404,946$350,999
20211,6856,629$473,362
20221,6316,991$468,733
20231,5136,625$487,034
20241,4536,435$562,691

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$211K$422K2015 Drug cost: $217,658 (USD; Tot_Drug_Cst)2016 Drug cost: $233,907 (USD; Tot_Drug_Cst)2017 Drug cost: $197,581 (USD; Tot_Drug_Cst)2018 Drug cost: $213,490 (USD; Tot_Drug_Cst)2019 Drug cost: $190,962 (USD; Tot_Drug_Cst)2020 Drug cost: $324,057 (USD; Tot_Drug_Cst)2021 Drug cost: $415,924 (USD; Tot_Drug_Cst)2022 Drug cost: $421,988 (USD; Tot_Drug_Cst)2023 Drug cost: $413,722 (USD; Tot_Drug_Cst)2024 Drug cost: $395,289 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20154011,934$217,658
20163631,690$233,907
20173411,793$197,581
20183431,915$213,490
20192741,412$190,962
20204171,667$324,057
20214492,111$415,924
20224622,224$421,988
20234762,213$413,722
20245912,710$395,289

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more1,2762,205$95
92083Exam of visual field with extended testing508552$50
92250Photography of the retina879937$30
92133Imaging of optic nerve495508$29
92020Exam of the internal drainage system of eye480499$22

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
RocklatanNetarsudil Mesylat/Latanoprost664,468$54,309
RestasisCyclosporine412,430$53,238
XiidraLifitegrast262,160$47,601
LumiganBimatoprost634,030$37,748
TravoprostTravoprost15910,827$35,381

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.22$498Tarsus Pharmaceuticals, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Theodore A. Gancayco, MD?

Tedicare shows public-source Medicare data for Theodore A. Gancayco, MD (NPI 1932217262), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Theodore A. Gancayco, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Theodore A. Gancayco, MD?

Theodore A. Gancayco, MD is linked to CHESAPEAKE EYE CARE AND LASER CENTER LLC (billing NPI 1548296262) in the available physician profile data.

Does Theodore A. Gancayco, MD have Open Payments data?

Theodore A. Gancayco, MD has 22 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.